Major Company Announces $650 Million Investment In Groton

GROTON, CT — Biopharmaceutical giant Pfizer has plans for a $650 million manufacturing technology center to be be built at its research and development center in Groton, according to a press release.

Construction is expected to begin on the approximately 220,000-square-foot facility in 2027 with the space operational in 2031.

The facility will produce ingredients and drug products that support Pfizer clinical trials. The project is being handled by AdvanceCT.

“Pfizer has a long and proud history of scientific innovation in Groton, where many of the discoveries that advance our pipeline begin. Building on that legacy, the new Manufacturing Technology Center will advance our ability to support clinical research and the development of new medicines for patients around the world,” Groton Site Head Raja Mangipudy said in a statement.

The project is expected to consolidate employees working on other facilities on the Groton campus into a "modern, purpose-built center."

Pfizer’s Groton campus is one of the company’s major research and development centers, supporting scientific discovery, pharmaceutical sciences, clinical development and the global supply of materials used in clinical research.

"The City of Groton has remained an important partner to Pfizer and will continue supporting the company as the Manufacturing Technology Center advances through planning, construction, and operational startup," according to the press release. "The investment builds on Pfizer’s longstanding presence in the community and further strengthens Groton’s position as a center for pharmaceutical research and development."

Pfizer opened its medical research laboratory operations in Groton in 1959, according to the company's website. The campus spans over 175 acres with over 2 million square feet of office and lab space.